These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11805542)

  • 41. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aminoglycosides].
    Palomino J; Pachón J
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):105-14; QUIZ 115, 120. PubMed ID: 12586036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Once-daily dosing of aminoglycoside antibiotics.
    Fisman DN; Kaye KM
    Infect Dis Clin North Am; 2000 Jun; 14(2):475-87. PubMed ID: 10829267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily aminoglycosides: practical guidelines.
    Prins JM; Speelman P
    Neth J Med; 1998 Jan; 52(1):1-9. PubMed ID: 9573735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ototoxicity of aminoglycoside antibiotics].
    Reiss M; Reiss G
    Praxis (Bern 1994); 2003 Jan; 92(4):127-33. PubMed ID: 12632843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aminoglycoside nephrotoxicity.
    Appel GB
    Am J Med; 1990 Mar; 88(3C):16S-20S; discussion 38S-42S. PubMed ID: 2180292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternative dosing strategy for aminoglycosides: impact on efficacy, nephrotoxicity, and ototoxicity.
    Chan GL
    DICP; 1989 Oct; 23(10):788-94. PubMed ID: 2683419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New trends in aminoglycoside dosing.
    Kuharcik CM; Craig AC
    ANNA J; 1994 Dec; 21(7):447-8, 468. PubMed ID: 7872827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.
    Horrevorts AM; Driessen OM; Michel MF; Kerrebijn KF
    Chest; 1988 Aug; 94(2 Suppl):120S-125S. PubMed ID: 3293937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Molecular mechanisms underlying renal accumulation of aminoglycoside antibiotics and mechanism-based approach for developing nonnephrotoxic aminoglycoside therapy].
    Nagai J
    Yakugaku Zasshi; 2006 May; 126(5):327-35. PubMed ID: 16679740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glomerular nephrotoxicity of aminoglycosides.
    Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
    Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aminoglycoside nephrotoxicity: keys to prevention.
    Levin ML
    J Crit Illn; 1994 Oct; 9(10):911-2, 915. PubMed ID: 10150695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients.
    Nicolau DP; Freeman CD; Belliveau PP; Nightingale CH; Ross JW; Quintiliani R
    Antimicrob Agents Chemother; 1995 Mar; 39(3):650-5. PubMed ID: 7793867
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Once-daily aminoglycoside dosing: An update on current literature.
    Stankowicz MS; Ibrahim J; Brown DL
    Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Once-daily aminoglycoside dosing.
    Baxter R
    Ann Intern Med; 1997 Feb; 126(4):330. PubMed ID: 9036808
    [No Abstract]   [Full Text] [Related]  

  • 57. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats.
    Kumar KV; Shifow AA; Naidu MU; Ratnakar KS
    Life Sci; 2000 May; 66(26):2603-11. PubMed ID: 10883738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.